Literature DB >> 23303639

Curcumin and liver disease.

Laura Vera-Ramirez1, Patricia Pérez-Lopez, Alfonso Varela-Lopez, McArmen Ramirez-Tortosa, Maurizio Battino, José L Quiles.   

Abstract

Liver diseases pose a major medical problem worldwide and a wide variety of herbs have been studied for the management of liver-related diseases. In this respect, curcumin has long been used in traditional medicine, and in recent years it has been the object of increasing research interest. In combating liver diseases, it seems clear that curcumin exerts a hypolipidic effect, which prevents the fatty acid accumulation in the hepatocytes that may result from metabolic imbalances, and which may cause nonalcoholic steatohepatitis. Another crucial protective activity of curcumin, not only in the context of chronic liver diseases but also regarding carcinogenesis and other age-related processes, is its potent antioxidant activity, which affects multiple processes and signaling pathways. The effects of curcumin on NF-κβ are crucial to our understanding of the potent hepatoprotective role of this herb-derived micronutrient. Because curcumin is a micronutrient that is closely related to cellular redox balance, its properties and activity give rise to a series of molecular reactions that in every case and biological situation affect the mitochondria.
Copyright © 2013 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303639     DOI: 10.1002/biof.1057

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  33 in total

Review 1.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Roles and mechanisms of stem cell in wound healing.

Authors:  Thurga Ayavoo; Karthikeyan Murugesan; Ashok Gnanasekaran
Journal:  Stem Cell Investig       Date:  2021-03-02

3.  Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect?

Authors:  B Li; L Wang; Q Lu; W Da
Journal:  Ir J Med Sci       Date:  2014-11-11       Impact factor: 1.568

4.  Antifungal Activity of Curcuminoids and Difluorinated Curcumin Against Clinical Isolates of Candida Species.

Authors:  Behnam Azari; Shaghayegh Zahmatkesh Moghadam; Hossein Zarrinfar; Aida Tasbandi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Protective Effects of p-CA Against Acute Liver Damage Induced by LPS/D-GalN in Wistar Albino Rats.

Authors:  Seerat Mehdi; Fiaz-Ud-Din Ahmad; Arslan Hussain Lodhi; Umair Khurshid; Ahmed Awais Khalid; Sheikh Safeena Sidiq; Liaqat Hussain; Mirza Shaharyar Baig
Journal:  Drug Des Devel Ther       Date:  2022-09-28       Impact factor: 4.319

Review 6.  Carbon-based Nanomaterials and Curcumin: A Review of Biosensing Applications.

Authors:  Mohammad Mohajeri; Behzad Behnam; Aida Tasbandi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Potent natural products and herbal medicines for treating liver fibrosis.

Authors:  Shao-Ru Chen; Xiu-Ping Chen; Jin-Jian Lu; Ying Wang; Yi-Tao Wang
Journal:  Chin Med       Date:  2015-04-15       Impact factor: 5.455

8.  Mitogen-activated protein kinase Hog1 is activated in response to curcumin exposure in the budding yeast Saccharomyces cerevisiae.

Authors:  Gajendra Kumar Azad; Vikash Singh; Mayur Jankiram Thakare; Shivani Baranwal; Raghuvir Singh Tomar
Journal:  BMC Microbiol       Date:  2014-12-19       Impact factor: 3.605

9.  Immunohistochemical and molecular study on the protective effect of curcumin against hepatic toxicity induced by paracetamol in Wistar rats.

Authors:  Mohamed Mohamed Soliman; Mohamed Abdo Nassan; Tamer Ahmed Ismail
Journal:  BMC Complement Altern Med       Date:  2014-11-29       Impact factor: 3.659

10.  Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells.

Authors:  Feng Zhang; Zili Zhang; Li Chen; Desong Kong; Xiaoping Zhang; Chunfeng Lu; Yin Lu; Shizhong Zheng
Journal:  J Cell Mol Med       Date:  2014-04-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.